PFG
AXDX

Piershale Financial Group’s Accelerate Diagnostics AXDX Stock Holding History

Piershale Financial Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-7
Closed -$1K – 123
2013
Q2 		$1K Buy
+7
New +$520 ﹤0.01% 83

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Piershale Financial Group's AXDX Position: Q3 2013 in Review

Piershale Financial Group sold out of Accelerate Diagnostics (AXDX) in Q3 2013, closing a stake of 7 shares — an estimated $1K sold.

Piershale Financial Group first reported a position in AXDX in Q2 2013 and held it in 1 quarter. The position peaked at $1K in Q2 2013. 47 funds tracked by Wall St. Rank hold AXDX as of Q3 2013.

  • Piershale Financial Group reported no remaining Accelerate Diagnostics position as of Q3 2013 after selling out during the quarter.
  • Piershale Financial Group sold 7 Accelerate Diagnostics shares in Q3 2013, an estimated $1K.
  • Piershale Financial Group first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 1 quarter.
  • Piershale Financial Group's Accelerate Diagnostics position peaked at $1K in Q2 2013.
  • 47 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2013.

Based on Piershale Financial Group's 13F filing for Q3 2013, filed 22 Oct 2013.